Cite

HARVARD Citation

    de Billy, E. et al. (n.d.). IMMU-13. DUAL IGF1R/IR INHIBITOR IN COMBINATION WITH GD2-CAR T-CELLS AS A POTENT THERAPEUTIC STRATEGY FOR H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS. Neuro-oncology. p. iii362. [Online]. 
  
Back to record